You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API lisinopril and hydrochlorothiazide


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing lisinopril and hydrochlorothiazide

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Almatica Pharma Inc ZESTORETIC lisinopril and hydrochlorothiazide 52427-435 DIBASIC CALCIUM PHOSPHATE DIHYDRATE
Almatica Pharma Inc ZESTORETIC lisinopril and hydrochlorothiazide 52427-435 FERRIC OXIDE RED
Almatica Pharma Inc ZESTORETIC lisinopril and hydrochlorothiazide 52427-435 FERRIC OXIDE YELLOW
Almatica Pharma Inc ZESTORETIC lisinopril and hydrochlorothiazide 52427-435 MAGNESIUM STEARATE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Excipients in ANDA-approved (generic) drugs containing lisinopril and hydrochlorothiazide

Company Ingredient NDC Excipient
Hikma Pharmaceuticals USA Inc lisinopril and hydrochlorothiazide 0143-1262 ANHYDROUS DIBASIC CALCIUM PHOSPHATE
Hikma Pharmaceuticals USA Inc lisinopril and hydrochlorothiazide 0143-1262 FD&C BLUE NO. 2
Hikma Pharmaceuticals USA Inc lisinopril and hydrochlorothiazide 0143-1262 LACTOSE MONOHYDRATE
Hikma Pharmaceuticals USA Inc lisinopril and hydrochlorothiazide 0143-1262 MAGNESIUM STEARATE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for lisinopril and hydrochlorothiazide

Excipient focus: ALUMINUM OXIDE

Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE

Excipient focus: CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS

lisinopril and hydrochlorothiazide drug variants containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS

Company Ingredient NDC
NCS HealthCare of KY Inc dba Vangard Labs lisinopril and hydrochlorothiazide 0615-7581
Aidarex Pharmaceuticals LLC lisinopril and hydrochlorothiazide 33261-828
Aphena Pharma Solutions - Tennessee LLC lisinopril and hydrochlorothiazide 43353-800
Bryant Ranch Prepack lisinopril and hydrochlorothiazide 63629-1679
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: COLLOIDAL SILICON DIOXIDE

Excipient focus: CROSPOVIDONE

Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C BLUE NO. 2--ALUMINUM LAKE

Excipient focus: FD&C RED NO. 40

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MANNITOL

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

lisinopril and hydrochlorothiazide drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO

Company Ingredient NDC
Hikma Pharmaceuticals USA Inc lisinopril and hydrochlorothiazide 0143-1262
Aphena Pharma Solutions - Tennessee LLC lisinopril and hydrochlorothiazide 43353-800
Aphena Pharma Solutions - Tennessee LLC lisinopril and hydrochlorothiazide 43353-975
A-S Medication Solutions lisinopril and hydrochlorothiazide 50090-1218
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: STARCH, CORN

Excipient focus: STARCH, PREGELATINIZED CORN

Excipient focus: TALC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group